Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Vitamin D May Raise Survival Rates Among Cancer Patients

By BiotechDaily International staff writers
Posted on 04 May 2014
Cancer patients who have higher levels of vitamin D when they are diagnosed are inclined to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to new research.

The findings are scheduled for publication in the July 2014 issue of the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM). The body naturally produces vitamin D after exposure to sunlight and absorbs it from specific foods. Vitamin D affects a variety of biologic mechanisms by binding to a protein called a vitamin D receptor, in addition to helping the body absorb the calcium and phosphorus required for healthy bones. This receptor is present in nearly every cell in the body.

“By reviewing studies that collectively examined vitamin D levels in 17,332 cancer patients, our analysis demonstrated that vitamin D levels are linked to better outcomes in several types of cancer,” said one of the study’s authors, Hui Wang, MD, PhD, a professor of the Institute for Nutritional Sciences at the Shanghai Institutes for Biological Sciences at the Chinese Academy of Sciences (Shanghai, China). “The results suggest vitamin D may influence the prognosis for people with breast cancer, colorectal cancer and lymphoma, in particular.”

The meta-analysis looked at the findings of 25 individual studies that measured vitamin D levels in cancer patients at the time of diagnosis and monitored survival rates. In most of the research, patients had their vitamin D levels tested before they underwent any treatment for cancer. The study found a 10 nmol/L increase in vitamin D levels was tied to a 4% increase in survival among cancer patients.

Researchers found the strongest association between vitamin D levels and survival in breast cancer, lymphoma and colorectal cancer. There was less evidence of a connection in people with Merkel cell carcinoma, lung cancer, gastric cancer, prostate cancer, leukemia, or melanoma but the available results were positive.

“Considering that vitamin D deficiency is a widespread issue all over the world, it is important to ensure that everyone has sufficient levels of this important nutrient,” Dr. Wang concluded. “Physicians need to pay close attention to vitamin D levels in people who have been diagnosed with cancer.”

Related Links:

Shanghai Institutes for Biological Sciences at the Chinese Academy of Sciences



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.